In part you are correct however if you look at the historical reported quarterly revenue from Temcell you will discover that sales are not evenly distributed throughout the year. By simply multiplying the December quarter by four you have also multiplied the natural low that occurred in the December quarter.
Saying that I do think that Temcell sales could begin to stabilize. The Takeda product will however dramatically increase royalties for several years to come.
In part you are correct however if you look at the historical...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.035(2.35%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $15.43M | 10.29M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 60710 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 80942 | 7 |
View Market Depth
| Last trade - 14.47pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |